Related Experiment Video
Updated: Jul 17, 2026
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Care pathways in early rheumatoid arthritis
Sasha Bernatsky1, Debbie Feldman, Ian Shrier
1Department of Medicine, Division of Clinical Epidemiology, McGill University Health Centre, Montreal, Quebec, Canada.
Canadian Family Physician Medecin De Famille Canadien
|February 7, 2007
Summary
Most family physicians correctly diagnose rheumatoid arthritis (RA), but few initiate disease-modifying antirheumatic drugs (DMARDs) before specialist referral, highlighting a need for improved early RA management.
Area of Science:
- Rheumatology
- Primary Care Medicine
- Clinical Diagnosis
Background:
- Rheumatoid arthritis (RA) requires timely diagnosis and treatment to prevent joint damage.
- Early intervention with disease-modifying antirheumatic drugs (DMARDs) is crucial for optimal patient outcomes.
Purpose of the Study:
- To assess the diagnostic accuracy of family physicians for rheumatoid arthritis (RA).
- To evaluate the reported management strategies of family physicians for RA patients.
- To identify potential gaps in the early management of inflammatory arthritis.
Main Methods:
- A mailed survey using self-administered questionnaires with clinical vignettes was employed.
- A computer-generated random sample of family physicians in the Province of Quebec participated.
- The study focused on the proportion of physicians recognizing RA and their reported management approaches.
Main Results:
- Nearly all surveyed family physicians (96.4%) correctly identified rheumatoid arthritis (RA) in vignette presentations.
- A significant majority (77.5%) reported referring RA patients to a rheumatologist.
- Notably, none of the physicians who suggested referral indicated initiating disease-modifying antirheumatic drugs (DMARDs) prior to referral.
Conclusions:
- Family physicians demonstrate high diagnostic accuracy for rheumatoid arthritis (RA).
- There is a significant gap in the initiation of disease-modifying antirheumatic drugs (DMARDs) during the early stages of RA management by primary care physicians.
- Optimizing care pathways and increasing the early use of DMARDs are essential for improving outcomes in new-onset inflammatory arthritis.
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...